Amphastar Pharmaceuticals, Inc. (AMPH)
Drug Manufacturers - Specialty & Generic · Healthcare · $841M
Intrinsic Value (Consensus)
$48.49
Current Price
$18.83
Margin of Safety
+157.5%
157.5% Below Intrinsic Value
Value: $48
Price: $19
Valuation Model Estimates
Current Price: $18.83
DCF (Discounted Cash Flow)
$113.54
Graham Number
$19.36
Earnings Power Value
$17.91
Relative Value (P/E)
$43.14
Dividend Discount Model
Not applicable
—
Consensus Value
$48.49
Model Assumptions
Discount Rate
10.3%
Growth Rate
25.9%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
82
Profitability
22/25
Strength
25/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong profitability — ROE of 22% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (26% YoY)
High free cash flow yield (14.4%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $1.67
- EPS (Forward)
- $2.10
- Book Value
- $9.98
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 22.0%
- Debt/Equity
- 9%
- Revenue Growth
- -1.7%
- Earnings Growth
- 25.9%
- Dividend Yield
- N/A
- Beta
- 0.84
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance